China Pharma Holdings (CPHI) Operating Expenses (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Operating Expenses came in at $1.4 million in Q1 2026, up 125.32% YoY from $622557.0 in Q1 2025, and up 3.83% on a QoQ basis from $1.4 million in Q4 2025.
China Pharma Holdings (CPHI) Operating Expenses (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Operating Expenses data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Operating Expenses rose 125.32% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 49.53% YoY) and the FY2025 annual result came in at $3.1 million, up 19.36% from the prior year.
- Operating Expenses grew to $1.4 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.4 million in Q1 2026 to a low of $309647.0 in Q2 2023.
- A 5-year average of $743464.3 and a median of $575403.0 in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses plunged 43.72% — and 2026, when it soared 125.32%.
- Tracing CPHI's Operating Expenses over 5 years: stood at $1.2 million in 2022, then slipped by 8.78% to $1.1 million in 2023, then fell by 6.32% to $1.0 million in 2024, then surged by 30.47% to $1.4 million in 2025, then climbed by 3.83% to $1.4 million in 2026.
- The last three Operating Expenses figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $568491.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.35 Mn | 42.04 Mn | 83,566.00 | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 568,491.00 |
| Jun 30, 2025 | 565,110.00 |
| Mar 31, 2025 | 622,557.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 565,608.00 |
| Jun 30, 2024 | 376,135.00 |
| Mar 31, 2024 | 626,028.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 480,352.00 |
| Jun 30, 2023 | 309,647.00 |
| Mar 31, 2023 | 575,403.00 |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 550,898.00 |
| Jun 30, 2022 | 550,212.00 |
| Mar 31, 2022 | 742,257.00 |
| Dec 31, 2021 | 950,626.00 |
| Sep 30, 2021 | 466,008.00 |
| Jun 30, 2021 | 823,948.00 |